117 related articles for article (PubMed ID: 20639111)
1. Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides.
Liu J; Antoon JW; Ponnapakkam A; Beckman BS; Foroozesh M
Bioorg Med Chem; 2010 Jul; 18(14):5316-22. PubMed ID: 20639111
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells.
Antoon JW; Liu J; Gestaut MM; Burow ME; Beckman BS; Foroozesh M
J Med Chem; 2009 Sep; 52(18):5748-52. PubMed ID: 19694470
[TBL] [Abstract][Full Text] [Related]
3. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics.
Antoon JW; Liu J; Ponnapakkam AP; Gestaut MM; Foroozesh M; Beckman BS
Cancer Chemother Pharmacol; 2010 May; 65(6):1191-5. PubMed ID: 20155475
[TBL] [Abstract][Full Text] [Related]
4. Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer.
Antoon JW; Beckman BS
Bioorg Med Chem Lett; 2012 Apr; 22(7):2624-8. PubMed ID: 22366655
[TBL] [Abstract][Full Text] [Related]
5. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
6. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.
Struckhoff AP; Bittman R; Burow ME; Clejan S; Elliott S; Hammond T; Tang Y; Beckman BS
J Pharmacol Exp Ther; 2004 May; 309(2):523-32. PubMed ID: 14742741
[TBL] [Abstract][Full Text] [Related]
7. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
8. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
[TBL] [Abstract][Full Text] [Related]
9. Tailoring structure-function and targeting properties of ceramides by site-specific cationization.
Szulc ZM; Bielawski J; Gracz H; Gustilo M; Mayroo N; Hannun YA; Obeid LM; Bielawska A
Bioorg Med Chem; 2006 Nov; 14(21):7083-104. PubMed ID: 16919460
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of a ceramide analog containing a disulfide linkage.
Bittman R; Li Z; Samadder P; Arthur G
Cancer Lett; 2007 Jun; 251(1):53-8. PubMed ID: 17141948
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and growth inhibitory activity of chiral 5-hydroxy-2-N-acyl-(3E)-sphingenines: ceramides with an unusual sphingoid backbone.
Chun J; Byun HS; Arthur G; Bittman R
J Org Chem; 2003 Jan; 68(2):355-9. PubMed ID: 12530860
[TBL] [Abstract][Full Text] [Related]
12. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates.
Liu J; Cui G; Zhao M; Cui C; Ju J; Peng S
Bioorg Med Chem; 2007 Dec; 15(24):7773-88. PubMed ID: 17888666
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and bioactivity of 4-alkyl(aryl)thioquinazoline derivatives.
Yang S; Li Z; Jin L; Song B; Liu G; Chen J; Chen Z; Hu D; Xue W; Xu R
Bioorg Med Chem Lett; 2007 Apr; 17(8):2193-6. PubMed ID: 17317179
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of D- and L-tyrosine-chlorambucil analogs active against breast cancer cell lines.
Descôteaux C; Leblanc V; Brasseur K; Gupta A; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2010 Dec; 20(24):7388-92. PubMed ID: 21051231
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures.
Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT
J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.
Díaz-Gavilán M; Conejo-García A; Cruz-López O; Núñez MC; Choquesillo-Lazarte D; González-Pérez JM; Rodríguez-Serrano F; Marchal JA; Aránega A; Gallo MA; Espinosa A; Campos JM
ChemMedChem; 2008 Jan; 3(1):127-35. PubMed ID: 18022976
[TBL] [Abstract][Full Text] [Related]
19. N-hydroxy-N'-aminoguanidines as anti-cancer lead molecule: QSAR, synthesis and biological evaluation.
Basu A; Sinha BN; Saiko P; Graser G; Szekeres T
Bioorg Med Chem Lett; 2011 Jun; 21(11):3324-8. PubMed ID: 21536434
[TBL] [Abstract][Full Text] [Related]
20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
